301 related articles for article (PubMed ID: 36078078)
1. Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.
Balsano R; Kruize Z; Lunardi M; Comandatore A; Barone M; Cavazzoni A; Re Cecconi AD; Morelli L; Wilmink H; Tiseo M; Garajovà I; van Zuylen L; Giovannetti E; Piccirillo R
Cells; 2022 Aug; 11(17):. PubMed ID: 36078078
[TBL] [Abstract][Full Text] [Related]
2. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
Lan XQ; Deng CJ; Wang QQ; Zhao LM; Jiao BW; Xiang Y
Gen Comp Endocrinol; 2024 Jul; 353():114513. PubMed ID: 38604437
[TBL] [Abstract][Full Text] [Related]
3. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
[TBL] [Abstract][Full Text] [Related]
4. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
Yakovenko A; Cameron M; Trevino JG
World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678
[TBL] [Abstract][Full Text] [Related]
5. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer.
Dasgupta A; Gibbard DF; Schmitt RE; Arneson-Wissink PC; Ducharme AM; Bruinsma ES; Hawse JR; Jatoi A; Doles JD
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2215095120. PubMed ID: 37585460
[TBL] [Abstract][Full Text] [Related]
6. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
8. Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.
Tsai VW; Lin S; Brown DA; Salis A; Breit SN
Int J Obes (Lond); 2016 Feb; 40(2):193-7. PubMed ID: 26620888
[TBL] [Abstract][Full Text] [Related]
9. Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15.
Tsai VW; Husaini Y; Manandhar R; Lee-Ng KK; Zhang HP; Harriott K; Jiang L; Lin S; Sainsbury A; Brown DA; Breit SN
J Cachexia Sarcopenia Muscle; 2012 Dec; 3(4):239-43. PubMed ID: 22936174
[TBL] [Abstract][Full Text] [Related]
10. Targeting the divergent TGFβ superfamily cytokine MIC-1/GDF15 for therapy of anorexia/cachexia syndromes.
Tsai VW; Brown DA; Breit SN
Curr Opin Support Palliat Care; 2018 Dec; 12(4):404-409. PubMed ID: 30382947
[TBL] [Abstract][Full Text] [Related]
11. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
12. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
13. Muscle myostatin signalling is enhanced in experimental cancer cachexia.
Costelli P; Muscaritoli M; Bonetto A; Penna F; Reffo P; Bossola M; Bonelli G; Doglietto GB; Baccino FM; Rossi Fanelli F
Eur J Clin Invest; 2008 Jul; 38(7):531-8. PubMed ID: 18578694
[TBL] [Abstract][Full Text] [Related]
14. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of blocking the activin signalling pathway.
Marino FE; Risbridger G; Gold E
Cytokine Growth Factor Rev; 2013 Oct; 24(5):477-84. PubMed ID: 23787160
[TBL] [Abstract][Full Text] [Related]
16. Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.
Ojima C; Noguchi Y; Miyamoto T; Saito Y; Orihashi H; Yoshimatsu Y; Watabe T; Takayama K; Hayashi Y; Itoh F
Cancer Sci; 2020 Aug; 111(8):2954-2964. PubMed ID: 32519375
[TBL] [Abstract][Full Text] [Related]
17. The possible role of myostatin in skeletal muscle atrophy and cachexia.
Jespersen J; Kjaer M; Schjerling P
Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
[TBL] [Abstract][Full Text] [Related]
18. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
19. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.
Breit SN; Tsai VW; Brown DA
Trends Mol Med; 2017 Dec; 23(12):1065-1067. PubMed ID: 29129392
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
